InvestorsHub Logo
icon url

olden_grumpini

09/28/21 10:35 AM

#376393 RE: Empiricst1 #376386

You can find the IPIX PR and a link to the Italian article here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161235600

The abstract concluded as follows: "These findings suggest that kevetrin may be a promising therapeutic option for patients with both wild-type and TP53-mutant AML."

I happen to be one of those crazy people who think kevetrin merits more resources.